Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Endothelial nitric oxide synthase (eNOS) coupling and NO vasodilation

eNOS Coupling & NO Vasodilation · Vascular endothelium and hemodynamics

Supplies the L-arginine substrate and prevents eNOS uncoupling, producing the vasoactive gas nitric oxide (NO), which relaxes vascular smooth muscle through the sGC-cGMP pathway.

Why it matters: A core target for arterial blood pressure regulation, erectile function support, and blood flow to the brain and peripheral microcirculation.

Molecular targets: eNOS, BH4 (tetrahydrobiopterin), sGC (soluble guanylate cyclase), cGMP

Supplements acting on this mechanism (ranked by strength and evidence)

Beetroot extract (inorganic nitrate donor)

★★★★★Mechanism evidence: grade A

Nitrate is reduced to nitrite by oral bacteria, then converted into NO, which acts on the sGC–cGMP pathway without depending on endothelial eNOS. In randomized human trials, nitrate or beetroot juice raised plasma nitrite and cGMP, and some studies also saw blood pressure fall.

L-citrulline

★★★★☆Mechanism evidence: grade A

Citrulline is converted to arginine through a pathway that includes argininosuccinate synthase (ASS), giving nitric oxide synthase an indirect substrate. A randomized crossover trial in humans measured higher plasma arginine, urinary nitrate and cGMP. This supports stronger NO-related signaling, but it cannot by itself prove that eNOS uncoupling was corrected.

Grape seed extract (OPC)

★★★☆☆Mechanism evidence: grade B

Small human studies have found changes in NO-related markers, but these markers cannot show whether the NO comes from endothelial eNOS, and the results are inconsistent. There is no direct human evidence of endothelial eNOS phosphorylation or of improvement in arteriosclerosis.

French maritime pine bark extract (Pycnogenol)

★★★☆☆Mechanism evidence: grade B

Small human trials showed that 180–200 mg/day can enhance nitric oxide-dependent vasodilation, and an NOS inhibitor abolished this enhancement. Upregulation of eNOS transcription and NO production itself were not measured directly. Evidence on the size of the improvement and on which populations benefit is still limited.

Standardized Ginkgo biloba leaf extract (EGb 761)

★★★☆☆Mechanism evidence: grade C

In cells, EGb 761 can enhance eNOS signaling, and in rats it produces a blood pressure-lowering effect that depends on nitric oxide. Changes in human blood flow or vasodilation cannot by themselves prove that eNOS is activated, and the specific mechanisms in the basilar artery of the brain and in the arterioles of the inner ear are not yet established.

Panax ginseng ginsenoside complex (Rg1, Rb1, Rg3)

★★★☆☆Mechanism evidence: grade C

Rg1 can increase eNOS phosphorylation and NO production in human endothelial cell experiments, and rat experiments also showed related results. However, a specific eNOS effect in humans has not been confirmed, and the improvement in flow-mediated dilation seen with red ginseng cannot by itself prove eNOS activation.

Astragaloside IV

★★★☆☆Mechanism evidence: grade C

Animal experiments show astragaloside IV can change eNOS phosphorylation and nitric oxide production, and related markers in kidney tissue also improved in diabetic rats. The claim that BH4 stabilizes eNOS coupling and prevents uncoupling has not been directly verified in humans at usual doses.

Micronized purified flavonoid fraction

★★★☆☆Mechanism evidence: grade C

Animal studies show that high-dose diosmin can improve vascular function markers linked to nitric oxide synthase. This result does not explain changes in venous tone, though, and no trial has shown that the venous tone effect of MPFF in humans is mediated by eNOS and nitric oxide.

Immediate-release niacin (vitamin B3)

★★★☆☆Mechanism evidence: grade C

The skin flushing from niacin comes from prostaglandin release after GPR109A receptor activation, not from eNOS activation. Vascular effects linked to eNOS have been seen in specific animal models, such as diabetic ischemia, but they cannot be extrapolated to a vasodilating effect at usual doses in humans.

Celery seed extract (3-NBP)

★★★☆☆Mechanism evidence: grade C

Butylphthalide can block L-type calcium channels in vascular smooth muscle, and this is not directly related to eNOS or nitric oxide. Changes related to eNOS have been seen in certain animal models of cerebral ischemia, but the route of administration and formulation differ from dietary supplements, and this has not been confirmed in humans.

Active ascorbic acid / liposomal vitamin C

★★★☆☆Mechanism evidence: grade C

In animal and cell studies, long-term vitamin C treatment increased BH4 and NOS activity in blood vessels, which suggests it may help maintain eNOS coupling. This mechanism has not been directly confirmed after oral intake in humans, and changes in vascular function are not enough on their own to show that BH4 is stabilized.

Standardized hawthorn leaf and flower extract (WS 1442 / hawthorn flavonoids)

★★★☆☆Mechanism evidence: grade C

In mice, WS 1442 restored eNOS phosphorylation and NO signaling in perivascular adipose tissue. In human oral studies, standardized hawthorn extract showed no dose response for FMD. Whether usual doses can keep activating coronary eNOS has not been confirmed.

Gynostemma saponins (Actiponin)

★★☆☆☆Mechanism evidence: grade A

Gynostemma extract can increase nitric oxide release from cultured endothelial cells and can relax isolated blood vessels. One randomized trial measured higher blood eNOS levels, but there is no direct evidence that this means better coronary or microvascular dilation.

Agmatine sulfate

★★☆☆☆Mechanism evidence: grade D

In isolated aorta experiments, agmatine affected eNOS phosphorylation, cGMP and relaxation responses, and brain eNOS expression changed in a rat ischemia model. However, these results do not establish endothelial coupling or vasodilation after oral intake, so “selective activation of eNOS” currently lacks support.

Lifestyle practices acting on this mechanism (ranked by strength and evidence)

Reducing salt intake

★★★☆☆Mechanism evidence: grade A

A small randomized crossover study found that salt restriction improved nitric oxide-mediated endothelial vasodilation, but it did not confirm any change in endothelial nitric oxide synthase expression.

Smoking cessation

★★☆☆☆Mechanism evidence: grade B

Human studies show that endothelium-dependent vasodilation improves after quitting smoking. These are indirect markers of nitric oxide–related vascular function and cannot prove a change in endothelial nitric oxide synthase itself. Quitters were also not randomly assigned to groups.

Open in the interactive app ›